Lucy Scientific Discovery Inc. (LSDI)
Stock analysis · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Lucy Scientific Discovery Inc. (LSDI) is a publicly traded company in the Healthcare sector. Latest price: $0.51. Market cap $906.91K. Trailing PE -0.72. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs). Established in 2017, this firm, formerly known as Hollyweed North Cannabis, Inc., is headquartered in Victoria, Canada.
Valuation
| P/E (TTM) | -0.72× |
|---|---|
| P/S (TTM) | 128.68× |
| P/B | 1.40× |
| PEG | 0.01× |
| P/FCF (TTM) | -0.20× |
| EV / EBITDA | -0.18× |
| EV / Sales | 144.98× |
| Earnings Yield | -137.71% |
| Free Cash Flow Yield | -503.51% |
Fundamentals
| Enterprise Value | $1.02M |
|---|---|
| Revenue (TTM) | $7.05K |
| Net Income (TTM) | -$1.25M |
| Free Cash Flow (TTM) | -$2.60M |
| Net Debt | $114.93K |
| Working Capital | $1.11M |
| Gross Margin | 36.15% |
| Operating Margin | -82919.74% |
| Net Margin | -127532.01% |
| Return on Equity | 18147.32% |
| Return on Invested Capital | -90.36% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap